Cargando…

Nelarabine in the Treatment of Refractory T-Cell Malignancies

Nelarabine is a nucleoside analog indicated for the treatment of adult and pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LBL) that is refractory or has relapsed after treatment with at least two chemotherapy regimens. After being first synthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roecker, Andrew M., Stockert, Amy, Kisor, David F.
Formato:	Texto
Lenguaje:	English
Publicado:	Libertas Academica 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999959/ https://www.ncbi.nlm.nih.gov/pubmed/21151585 http://dx.doi.org/10.4137/CMO.S4364

Ejemplares similares

Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia
por: Reilly, Kelly M, et al.
Publicado: (2009)

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
por: Shimony, Shai, et al.
Publicado: (2022)

Rhabdomyolysis induced by nelarabine
por: Späth, Christian, et al.
Publicado: (2022)

Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
por: Cooper, Todd M
Publicado: (2007)

Nelarabine Associated Myotoxicity and Rhabdomyolysis
por: Haider, Mahnur, et al.
Publicado: (2015)

MRI findings of nelarabine‐related rhabdomyolysis in a patient with refractory T‐cell acute lymphoblastic leukemia
por: Mukai, Daiki, et al.
Publicado: (2023)

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant
por: McEwan, Ashley, et al.
Publicado: (2020)

Nelarabine-induced rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia: a case report
por: Utsumi, Akari, et al.
Publicado: (2022)

SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine
por: Rothenburger, Tamara, et al.
Publicado: (2020)

Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line
por: Yamauchi, Takahiro, et al.
Publicado: (2014)

Rational Design of a Thermostable 2′-Deoxyribosyltransferase for Nelarabine Production by Prediction of Disulfide Bond Engineering Sites
por: Cruz, Guillermo, et al.
Publicado: (2022)

Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases
por: Molle, Ingolf, et al.
Publicado: (2022)

Clinical Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
por: Tisi, Maria Chiara, et al.
Publicado: (2015)

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway
por: Lonetti, Annalisa, et al.
Publicado: (2016)

ALL-083 ALLogeneic Hematopoietic Stem Cell Transplantation of a R/R T-ALL Patient Given Nelarabine, 3 Weeks Post Moderate COVID-19 Infection in the Local Setting
por: Uong, Flaryll
Publicado: (2022)

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
por: Kisor, David F, et al.
Publicado: (2021)

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
por: Bodiford, Andrew, et al.
Publicado: (2014)

Expanding Pharmacist and Student Pharmacist Access to Genetics/Genomics/Pharmacogenomics Competency Education
por: Kisor, David F, et al.
Publicado: (2019)

Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma
por: Galimberti, S, et al.
Publicado: (2010)

Treatment of Refractory Metastatic Renal Cell Carcinoma
por: Vento, Joseph A., et al.
Publicado: (2022)

Pericardioperitoneal shunt for the treatment of refractory non-malignant pericardial effusion
por: Masaru, Ishida, et al.
Publicado: (2022)

Review and Updates on the Treatment of Refractory and Super Refractory Status Epilepticus
por: Alolayan, Yazeed S., et al.
Publicado: (2021)

Expectations for first single-top studies in CMS in pp collisions
por: Roecker, Steffen
Publicado: (2010)

Measurements of single top quark processes with CMS
por: Roecker, Steffen
Publicado: (2013)

Palliative management of refractory dyspnea in COPD
por: Uronis, Hope E, et al.
Publicado: (2006)

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
por: Armstrong, Andrew J, et al.
Publicado: (2007)

Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
por: Samad, Nousheen, et al.
Publicado: (2010)

Treatment approaches in relapsed or refractory peripheral T-cell lymphomas
por: Foster, Cheryl, et al.
Publicado: (2020)

Biologically-Based Complementary and Alternative Medicine (CAM) Use in Cancer Patients: The Good, the Bad, the Misunderstood
por: Knecht, Kathryn, et al.
Publicado: (2020)

Cellular immunotherapy for refractory hematological malignancies
por: Reagan, John L, et al.
Publicado: (2013)

Malignant refractory priapism: An urologist's nightmare
por: Prabhuswamy, Vinod Kumar, et al.
Publicado: (2019)

The Resonance and the Allium ureteral stents in the treatment of non-malignant refractory ureterostenosis
por: Gao, Wei, et al.
Publicado: (2021)

Uses of industrial minerals, rocks and freshwater /
por: Chatterjee, Kaulir Kisor
Publicado: (2009)

Editorial: Complementary and Alternative Medicine Use in Cancer Patients
por: Knecht, Kathryn T., et al.
Publicado: (2022)

Treatment-refractory giardiasis: challenges and solutions
por: Lalle, Marco, et al.
Publicado: (2018)

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
por: Zhang, Honghong, et al.
Publicado: (2017)

Treatment of Refractory Chronic Urticaria
por: Mehta, Aayushi, et al.
Publicado: (2015)

Pharmacokinetic data of synthetic cathinones in female Sprague-Dawley rats
por: Grecco, Gregory G., et al.
Publicado: (2018)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context
por: Abdulhaq, Haifaa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_to4c8p3csp5b7p6sndcg8ai712